This is our story of rapidly scaling up pharmacovigilance for a leading Clinical Research Organization (CRO) through Software-as-a-Service (SaaS) analytics, ensuring data security, cost efficiency and superior reporting capabilities.
As we know…
The volume and complexity of pharmacovigilance data continue to escalate, and pharmaceutical companies face mounting challenges in effectively managing, analyzing and reporting this deluge of information.
To overcome these roadblocks, the sector is leveraging advanced digital and analytics solutions to construct stringent data security frameworks and devise robust, scalable and self-serve reporting mechanisms. Recent innovations have led to cost-efficient strategies, empowering pharmaceutical entities to navigate the complexities of pharmacovigilance while fortifying safety standards and optimizing operational efficiency.
The challenge for the client was…
Managing pharmacovigilance data and reporting across multiple tenants on their Argus Safety platform. With over 250 tenants and a vast repository of case data, the client required a robust reporting and analytics solution that could ensure data security, scalability and flexibility while reducing overall costs.
Key focus areas for the client included:
A Complex Tenant Structure
Managing numerous tenants on a single license and platform, each requiring secure access to their own data without compromising privacy or security
Reporting Diversity
Addressing various reporting needs across tenants, the client sought a unified solution for generating pixel-perfect reports, self-service reporting and data visualization
Data Integration
Beyond Argus Safety serving as the primary data source, the client needed the flexibility to integrate additional data sources, such as clinical systems and file systems, into their reporting framework
Stepping in as a strategic partner…
WNS implemented a comprehensive, SaaS analytics-led pharmacovigilance and compliance solution. Key aspects of the solution included:
Assessment and Analysis
Conducting an in-depth analysis of the client's reporting and security needs and challenges to identify pain points and areas for improvement
Implementation of the SaaS Solution
Harnessing our proprietary solution to provide end-users with self-service reporting capabilities, effortlessly generating line listings, summary tabulations and charts
Data Security and Scalability
Leveraging Snowflake for the data lake to ensure data security across tenants while enabling vertical and horizontal scalability to support high-case volumes
Multi-source Data Integration
Implementing smart connectors to ingest data from multiple sources into the data lake, enabling seamless integration with Argus Safety and other safety systems
Cost-effective Cloud Deployment
Deploying all components on the cloud with a usage-based cost model to enable a significantly lower Total Cost of Ownership (TCO) for the client
As a result of the SaaS deployment…
Our client acquired rapid report development capabilities for quick, impactful data insights and trends. This facilitated informed decision-making, compliance management and operational performance assessment. The solution enhanced data security by ensuring safe access controls so that each tenant could access only their respective data, maintaining data privacy and compliance.
Key outcomes include:
~
percent cost savings
compared to traditional reporting solutions, owing to a usage-based cost model
~
percent
faster turnaround time
on ad-hoc reporting and data analysis requests
Seamless scaling up
from ~
initial
caseload to
million+
cases
With enhanced reporting capabilities, improved decision-making and significant cost savings, our client is well-positioned for future growth in the highly competitive pharmaceutical landscape.
FAQs
1. How can pharmaceutical companies modernize pharmacovigilance reporting without compromising regulatory compliance?
Modern pharmacovigilance requires secure, scalable platforms capable of managing growing adverse event volumes while meeting global regulatory requirements. Cloud-native analytics, automated reporting and robust governance improve reporting speed, data quality and audit readiness. WNS helps pharmaceutical companies and CROs modernize pharmacovigilance through SaaS-enabled analytics platforms that strengthen compliance while improving operational efficiency.
2. How can AI and advanced analytics improve pharmacovigilance operations and drug safety monitoring?
AI-powered analytics enables organizations to automate adverse event reporting, accelerate signal detection, identify safety trends and generate self-service insights across multiple data sources. These capabilities improve decision-making while reducing manual effort. WNS combines advanced analytics, cloud technologies and pharmacovigilance expertise to help life sciences organizations build intelligent drug safety ecosystems that improve patient safety and operational performance.
3. What challenges do global pharmaceutical companies face when managing pharmacovigilance data at scale?
Organizations frequently struggle with fragmented safety systems, multiple data sources, multi-tenant environments, reporting complexity and increasing regulatory expectations. These challenges slow reporting and increase operational costs. WNS addresses these issues through centralized data management, secure cloud architecture, intelligent data integration and scalable analytics frameworks that enable faster, more reliable pharmacovigilance operations.
4. Why is self-service pharmacovigilance analytics becoming a strategic capability for life sciences organizations?
Business users increasingly require immediate access to safety insights without depending on manual report generation. Self-service analytics enables pharmacovigilance teams to create dashboards, line listings, summary reports and regulatory insights faster, improving operational agility and compliance readiness. WNS delivers intelligent reporting platforms that empower users with secure, real-time pharmacovigilance intelligence while maintaining strong governance.
5. Why should pharmaceutical companies partner with WNS for pharmacovigilance analytics transformation?
WNS combines deep life sciences expertise with AI, advanced analytics, cloud-native SaaS platforms and pharmacovigilance domain knowledge to modernize end-to-end drug safety operations. From Argus Safety reporting and multi-source data integration to self-service analytics, regulatory reporting and pharmacovigilance intelligence, WNS helps pharmaceutical organizations reduce costs, improve reporting speed, strengthen compliance and scale global drug safety operations with confidence